David N. Assis

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “A Systematic Review of Patient‐Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis”.

A Systematic Review of Patient‐Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis

Hepatology Communications(2020)10.1002/hep4.1567

N/A

0DataRank · unranked

20 citations

Sarah R. Lieber, Michael E. Rogers, Andrew M. Moon, Marci M. Loiselle, Jennifer S. Walker +5 more

Immunopathogenesis of Autoimmune Hepatitis†

Clinical Liver Disease(2020)10.1002/cld.873

N/A

0DataRank · unranked

24 citations

David N. Assis

Advancing diagnosis and management of liver disease in adults through exome sequencing

EBioMedicine(2023)10.1016/j.ebiom.2023.104747

N/A

0DataRank · unranked

32 citations

Aaron Hakim, Chigoziri Konkwo, Aimée M. Deaton, Lucas D. Ward, Marina G. Silveira +12 more

Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data

Vaccine(2024)10.1016/j.vaccine.2024.01.021

N/A

0DataRank · unranked

5 citations

David N. Assis, Cara L. Mack, Héctor S. Izurieta, Luigi Muratori, Alma Muñoz +5 more

A liquid biopsy-RNAseq method for monitoring the expression of genes involved in drug disposition: Proof-of-concept application to cholestatic liver disease

Journal of Pharmaceutical and Biomedical Analysis(2025)10.1016/j.jpba.2025.117244

N/A

0DataRank · unranked

1 citations

Teresa Sierra, Colleen M. Hayes, David N. Assis, Amin Rostami‐Hodjegan, Nisanne S. Ghonem +2 more